
Azenta (AZTA) Stock Forecast & Price Target
Azenta (AZTA) Analyst Ratings
Bulls say
Azenta Inc has demonstrated a positive trajectory, with an adjusted EBITDA margin of 13.0%, reflecting a year-over-year increase of 230 basis points, surpassing consensus expectations. The company's gross margin is projected to improve by approximately 200 basis points, alongside operational leverage contributing an additional 100 basis points, indicating a focus on enhancing profitability. Furthermore, the bull case scenario anticipates revenue growth from both its Sample Management Solutions and Multiomics segments, which could lead to accelerated margin improvement and robust earnings growth over the coming years.
Bears say
Azenta Inc's financial outlook appears negative due to a decline in its adjusted gross margin to 46.7%, which fell short of consensus expectations, primarily influenced by decreased margins in its Multiomics segment, despite some operational efficiencies in its Sample Management Solutions (SMS). The company's revenue from SMS of $86 million missed consensus estimates and reflected stagnant organic growth, with anticipated revenue declines of 1-2% year-over-year for the upcoming quarter attributed to constrained customer budgets and external factors such as a potential government shutdown. Additionally, lowered revenue projections for FY26 and FY27, alongside concerns about competitive pressures in Multiomics and slower traction in SMS, raise further caution about the potential for margin contraction and stagnant or negative earnings growth.
This aggregate rating is based on analysts' research of Azenta and is not a guaranteed prediction by Public.com or investment advice.
Azenta (AZTA) Analyst Forecast & Price Prediction
Start investing in Azenta (AZTA)
Order type
Buy in
Order amount
Est. shares
0 shares